{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:14:46Z","timestamp":1792664086637,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012546","name":"Chongqing Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["CSTB2022NSCQ-BHX0636"],"award-info":[{"award-number":["CSTB2022NSCQ-BHX0636"]}],"id":[{"id":"10.13039\/100012546","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation, China","doi-asserted-by":"crossref","award":["81872329"],"award-info":[{"award-number":["81872329"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hotspot driver mutations presented by human leukocyte antigens might be recognized by anti-tumor T cells. Based on their advantages of tumor-specificity and immunogenicity, neoantigens derived from hotspot mutations, such as PIK3CA<jats:sup>H1047L<\/jats:sup>, may serve as emerging targets for cancer immunotherapies. NetMHCpan V4.1 was utilized for predicting neoepitopes of <jats:italic>PIK3CA<\/jats:italic> hotspot mutation. Using in vitro stimulation, antigen-specific T cells targeting the HLA-A*11:01-restricted <jats:italic>PIK3CA<\/jats:italic> mutation were isolated from healthy donor-derived peripheral blood mononuclear cells. T cell receptors (TCRs) were cloned using single-cell PCR and sequencing. Their functionality was assessed through T cell activation markers, cytokine production and cytotoxic response to cancer cell lines pulsed with peptides or transduced genes of mutant <jats:italic>PIK3CA<\/jats:italic>. Immunogenic mutant antigens from <jats:italic>PIK3CA<\/jats:italic> and their corresponding CD8<jats:sup>+<\/jats:sup> T cells were identified. These <jats:italic>PIK3CA<\/jats:italic> mutation-specific CD8<jats:sup>+<\/jats:sup> T cells were subsequently enriched, and their TCRs were isolated. The TCR clones exhibited mutation-specific and HLA-restricted reactivity, demonstrating varying degrees of functional avidity. Identified TCR genes were transferred into CD8<jats:sup>+<\/jats:sup> Jurkat cells and primary T cells deficient of endogenous TCRs. TCR-expressing cells demonstrated specific recognition and reactivity against the PIK3CA<jats:sup>H1047L<\/jats:sup> peptide presented by HLA-A*11:01-expressing K562 cells. Furthermore, mutation-specific TCR-T cells demonstrated an elevation in cytokine production and profound cytotoxic effects against HLA-A*11:01<jats:sup>+<\/jats:sup> malignant cell lines harboring PIK3CA<jats:sup>H1047L<\/jats:sup>. Our data demonstrate the immunogenicity of an HLA-A*11:01-restricted <jats:italic>PIK3CA<\/jats:italic> hotspot mutation and its targeting therapeutic potential, together with promising candidates of TCR-T cell therapy.<\/jats:p>","DOI":"10.1007\/s00262-024-03729-y","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T13:10:44Z","timestamp":1717506644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T cell receptors for cancer immunotherapy targeting hotspot driver mutations"],"prefix":"10.1007","volume":"73","author":[{"given":"Meiying","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bozhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaxia","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haochen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengchun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"key":"3729_CR1","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm.4333","volume":"23","author":"A Zehir","year":"2017","unstructured":"Zehir A, Benayed R, Shah RH, Syed A, Middha S, Kim HR, Srinivasan P, Gao J, Chakravarty D, Devlin SM, Hellmann MD, Barron DA, Schram AM, Hameed M, Dogan S, Ross DS, Hechtman JF, DeLair DF, Yao J, Mandelker DL, Cheng DT, Chandramohan R, Mohanty AS, Ptashkin RN, Jayakumaran G, Prasad M, Syed MH, Rema AB, Liu ZY, Nafa K, Borsu L, Sadowska J, Casanova J, Bacares R, Kiecka IJ, Razumova A, Son JB, Stewart L, Baldi T, Mullaney KA, Al-Ahmadie H, Vakiani E, Abeshouse AA, Penson AV, Jonsson P, Camacho N, Chang MT, Won HH, Gross BE, Kundra R, Heins ZJ, Chen HW, Phillips S, Zhang H, Wang J, Ochoa A, Wills J, Eubank M, Thomas SB, Gardos SM, Reales DN, Galle J, Durany R, Cambria R, Abida W, Cercek A, Feldman DR, Gounder MM, Hakimi AA, Harding JJ, Iyer G, Janjigian YY, Jordan EJ, Kelly CM, Lowery MA, Morris LGT, Omuro AM, Raj N, Razavi P, Shoushtari AN, Shukla N, Soumerai TE, Varghese AM, Yaeger R, Coleman J, Bochner B, Riely GJ, Saltz LB, Scher HI, Sabbatini PJ, Robson ME, Klimstra DS, Taylor BS, Baselga J, Schultz N, Hyman DM, Arcila ME, Solit DB, Ladanyi M, Berger MF (2017) Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med 23:703\u2013713","journal-title":"Nat Med"},{"key":"3729_CR2","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.1073\/pnas.0701005104","volume":"104","author":"M Gymnopoulos","year":"2007","unstructured":"Gymnopoulos M, Elsliger MA, Vogt PK (2007) Rare cancer-specific mutations in PIK3CA show gain of function. Proc Natl Acad Sci U S A 104:5569\u20135574","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3729_CR3","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1158\/2159-8290.CD-18-0264","volume":"8","author":"B O'Leary","year":"2018","unstructured":"O\u2019Leary B, Cutts RJ, Liu Y, Hrebien S, Huang X, Fenwick K, Andre F, Loibl S, Loi S, Garcia-Murillas I, Cristofanilli M, Huang Bartlett C, Turner NC (2018) The genetic landscape and clonal evolution of breast cancer resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial. Cancer Discov 8:1390\u20131403","journal-title":"Cancer Discov"},{"issue":"563\u2013575","key":"3729_CR4","volume":"185","author":"B Nguyen","year":"2022","unstructured":"Nguyen B, Fong C, Luthra A, Smith SA, DiNatale RG, Nandakumar S, Walch H, Chatila WK, Madupuri R, Kundra R, Bielski CM, Mastrogiacomo B, Donoghue MTA, Boire A, Chandarlapaty S, Ganesh K, Harding JJ, Iacobuzio-Donahue CA, Razavi P, Reznik E, Rudin CM, Zamarin D, Abida W, Abou-Alfa GK, Aghajanian C, Cercek A, Chi P, Feldman D, Ho AL, Iyer G, Janjigian YY, Morris M, Motzer RJ, O\u2019Reilly EM, Postow MA, Raj NP, Riely GJ, Robson ME, Rosenberg JE, Safonov A, Shoushtari AN, Tap W, Teo MY, Varghese AM, Voss M, Yaeger R, Zauderer MG, Abu-Rustum N, Garcia-Aguilar J, Bochner B, Hakimi A, Jarnagin WR, Jones DR, Molena D, Morris L, Rios-Doria E, Russo P, Singer S, Strong VE, Chakravarty D, Ellenson LH, Gopalan A, Reis-Filho JS, Weigelt B, Ladanyi M, Gonen M, Shah SP, Massague J, Gao J, Zehir A, Berger MF, Solit DB, Bakhoum SF, Sanchez-Vega F, Schultz N (2022) Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients. Cell 185(563\u2013575):e511","journal-title":"Cell"},{"key":"3729_CR5","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1056\/NEJMoa2119662","volume":"386","author":"R Leidner","year":"2022","unstructured":"Leidner R, Sanjuan Silva N, Huang H, Sprott D, Zheng C, Shih YP, Leung A, Payne R, Sutcliffe K, Cramer J, Rosenberg SA, Fox BA, Urba WJ, Tran E (2022) Neoantigen T-cell receptor gene therapy in pancreatic cancer. N Engl J Med 386:2112\u20132119","journal-title":"N Engl J Med"},{"key":"3729_CR6","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1158\/2326-6066.CIR-22-0040","volume":"10","author":"SP Kim","year":"2022","unstructured":"Kim SP, Vale NR, Zacharakis N, Krishna S, Yu Z, Gasmi B, Gartner JJ, Sindiri S, Malekzadeh P, Deniger DC, Lowery FJ, Parkhurst MR, Ngo LT, Ray S, Li YF, Hill V, Florentin M, Masi RV, Paria BC, Levin N, Bera A, Hedges EA, Choi A, Chatani PD, Parikh AY, Levi S, Seitter S, Lu YC, Zheng Z, Prickett TD, Jia L, Hernandez JM, Hoang CD, Robbins PF, Goff SL, Sherry RM, Yang JC, Rosenberg SA (2022) Adoptive cellular therapy with autologous tumor-infiltrating lymphocytes and T-cell receptor-engineered T cells targeting common p53 neoantigens in human solid tumors. Cancer Immunol Res 10:932\u2013946","journal-title":"Cancer Immunol Res"},{"key":"3729_CR7","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1002\/ijc.34453","volume":"152","author":"M Ishihara","year":"2023","unstructured":"Ishihara M, Nishida Y, Kitano S, Kawai A, Muraoka D, Momose F, Harada N, Miyahara Y, Seo N, Hattori H, Takada K, Emori M, Kakunaga S, Endo M, Matsumoto Y, Sasada T, Sato E, Yamada T, Matsumine A, Nagata Y, Watanabe T, Kageyama S, Shiku H (2023) A phase 1 trial of NY-ESO-1-specific TCR-engineered T-cell therapy combined with a lymph node-targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma. Int J Cancer 152:2554\u20132566","journal-title":"Int J Cancer"},{"key":"3729_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41591-020-01225-1","volume":"27","author":"NB Nagarsheth","year":"2021","unstructured":"Nagarsheth NB, Norberg SM, Sinkoe AL, Adhikary S, Meyer TJ, Lack JB, Warner AC, Schweitzer C, Doran SL, Korrapati S, Stevanovic S, Trimble CL, Kanakry JA, Bagheri MH, Ferraro E, Astrow SH, Bot A, Faquin WC, Stroncek D, Gkitsas N, Highfill S, Hinrichs CS (2021) TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers. Nat Med 27:419\u2013425","journal-title":"Nat Med"},{"issue":"820\u2013832","key":"3729_CR9","volume":"31","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Kwok-Shing Ng P, Kucherlapati M, Chen F, Liu Y, Tsang YH, de Velasco G, Jeong KJ, Akbani R, Hadjipanayis A, Pantazi A, Bristow CA, Lee E, Mahadeshwar HS, Tang J, Zhang J, Yang L, Seth S, Lee S, Ren X, Song X, Sun H, Seidman J, Luquette LJ, Xi R, Chin L, Protopopov A, Westbrook TF, Shelley CS, Choueiri TK, Ittmann M, Van Waes C, Weinstein JN, Liang H, Henske EP, Godwin AK, Park PJ, Kucherlapati R, Scott KL, Mills GB, Kwiatkowski DJ, Creighton CJ (2017) A pan-cancer proteogenomic atlas of PI3K\/AKT\/mTOR pathway alterations. Cancer Cell 31(820\u2013832):e823","journal-title":"Cancer Cell"},{"key":"3729_CR10","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1002\/cam4.4844","volume":"11","author":"H Wu","year":"2022","unstructured":"Wu H, Feng H, Miao X, Ma J, Liu C, Zhang L, Yang L (2022) Construction and validation of a prognostic model based on 11 lymph node metastasis-related genes for overall survival in endometrial cancer. Cancer Med 11:4641\u20134655","journal-title":"Cancer Med"},{"key":"3729_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature12881","volume":"506","author":"AI Ojesina","year":"2014","unstructured":"Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I, Pugh TJ, Cherniack AD, Ambrogio L, Cibulskis K, Bertelsen B, Romero-Cordoba S, Trevino V, Vazquez-Santillan K, Guadarrama AS, Wright AA, Rosenberg MW, Duke F, Kaplan B, Wang R, Nickerson E, Walline HM, Lawrence MS, Stewart C, Carter SL, McKenna A, Rodriguez-Sanchez IP, Espinosa-Castilla M, Woie K, Bjorge L, Wik E, Halle MK, Hoivik EA, Krakstad C, Gabino NB, Gomez-Macias GS, Valdez-Chapa LD, Garza-Rodriguez ML, Maytorena G, Vazquez J, Rodea C, Cravioto A, Cortes ML, Greulich H, Crum CP, Neuberg DS, Hidalgo-Miranda A, Escareno CR, Akslen LA, Carey TE, Vintermyr OK, Gabriel SB, Barrera-Saldana HA, Melendez-Zajgla J, Getz G, Salvesen HB, Meyerson M (2014) Landscape of genomic alterations in cervical carcinomas. Nature 506:371\u2013375","journal-title":"Nature"},{"issue":"125\u2013136","key":"3729_CR12","volume":"33","author":"R Yaeger","year":"2018","unstructured":"Yaeger R, Chatila WK, Lipsyc MD, Hechtman JF, Cercek A, Sanchez-Vega F, Jayakumaran G, Middha S, Zehir A, Donoghue MTA, You D, Viale A, Kemeny N, Segal NH, Stadler ZK, Varghese AM, Kundra R, Gao J, Syed A, Hyman DM, Vakiani E, Rosen N, Taylor BS, Ladanyi M, Berger MF, Solit DB, Shia J, Saltz L, Schultz N (2018) Clinical sequencing defines the genomic landscape of metastatic colorectal cancer. Cancer Cell 33(125\u2013136):e123","journal-title":"Cancer Cell"},{"key":"3729_CR13","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, Boutselakis H, Cole CG, Creatore C, Dawson E, Fish P, Harsha B, Hathaway C, Jupe SC, Kok CY, Noble K, Ponting L, Ramshaw CC, Rye CE, Speedy HE, Stefancsik R, Thompson SL, Wang S, Ward S, Campbell PJ, Forbes SA (2019) COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res 47:D941\u2013D947","journal-title":"Nucleic Acids Res"},{"key":"3729_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.833017","volume":"13","author":"MJW Sim","year":"2022","unstructured":"Sim MJW, Sun PD (2022) T cell recognition of tumor neoantigens and insights into T cell immunotherapy. Front Immunol 13:833017","journal-title":"Front Immunol"},{"key":"3729_CR15","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.3390\/cancers13164245","volume":"13","author":"DJ Verdon","year":"2021","unstructured":"Verdon DJ, Jenkins MR (2021) Identification and targeting of mutant peptide neoantigens in cancer immunotherapy. Cancers 13:4245","journal-title":"Cancers"},{"key":"3729_CR16","doi-asserted-by":"publisher","first-page":"D1053","DOI":"10.1093\/nar\/gkac1011","volume":"51","author":"DJ Barker","year":"2023","unstructured":"Barker DJ, Maccari G, Georgiou X, Cooper MA, Flicek P, Robinson J, Marsh SGE (2023) The IPD-IMGT\/HLA database. Nucleic Acids Res 51:D1053\u2013D1060","journal-title":"Nucleic Acids Res"},{"key":"3729_CR17","first-page":"D783","volume":"48","author":"FF Gonzalez-Galarza","year":"2020","unstructured":"Gonzalez-Galarza FF, McCabe A, Santos E, Jones J, Takeshita L, Ortega-Rivera ND, Cid-Pavon GMD, Ramsbottom K, Ghattaoraya G, Alfirevic A, Middleton D, Jones AR (2020) Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools. Nucleic Acids Res 48:D783\u2013D788","journal-title":"Nucleic Acids Res"},{"key":"3729_CR18","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1038\/s41467-021-24562-2","volume":"12","author":"AS Bear","year":"2021","unstructured":"Bear AS, Blanchard T, Cesare J, Ford MJ, Richman LP, Xu C, Baroja ML, McCuaig S, Costeas C, Gabunia K, Scholler J, Posey AD Jr, O\u2019Hara MH, Smole A, Powell DJ Jr, Garcia BA, Vonderheide RH, Linette GP, Carreno BM (2021) Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting. Nat Commun 12:4365","journal-title":"Nat Commun"},{"key":"3729_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2021.100084","volume":"1","author":"J Choi","year":"2021","unstructured":"Choi J, Goulding SP, Conn BP, McGann CD, Dietze JL, Kohler J, Lenkala D, Boudot A, Rothenberg DA, Turcott PJ, Srouji JR, Foley KC, Rooney MS, van Buuren MM, Gaynor RB, Abelin JG, Addona TA, Juneja VR (2021) Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutations. Cell Rep Methods 1:100084","journal-title":"Cell Rep Methods"},{"key":"3729_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","volume":"23","author":"G Oliveira","year":"2023","unstructured":"Oliveira G, Wu CJ (2023) Dynamics and specificities of T cells in cancer immunotherapy. Nat Rev Cancer 23:295\u2013316","journal-title":"Nat Rev Cancer"},{"key":"3729_CR21","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/s41573-023-00809-z","volume":"22","author":"CA Klebanoff","year":"2023","unstructured":"Klebanoff CA, Chandran SS, Baker BM, Quezada SA, Ribas A (2023) T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome. Nat Rev Drug Discov 22:996\u20131017","journal-title":"Nat Rev Drug Discov"},{"key":"3729_CR22","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1038\/s41596-019-0170-6","volume":"14","author":"M Ali","year":"2019","unstructured":"Ali M, Foldvari Z, Giannakopoulou E, Boschen ML, Stronen E, Yang W, Toebes M, Schubert B, Kohlbacher O, Schumacher TN, Olweus J (2019) Induction of neoantigen-reactive T cells from healthy donors. Nat Protoc 14:1926\u20131943","journal-title":"Nat Protoc"},{"key":"3729_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107848","volume":"98","author":"S Chen","year":"2021","unstructured":"Chen S, Zhang J, Shen M, Han X, Li S, Hu C, Wang W, Li L, Du L, Pang D, Tao K, Jin A (2021) p38 inhibition enhances TCR-T cell function and antagonizes the immunosuppressive activity of TGF-\u03b2. Int Immunopharmacol 98:107848","journal-title":"Int Immunopharmacol"},{"key":"3729_CR24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.gendis.2021.05.006","volume":"9","author":"C Hu","year":"2022","unstructured":"Hu C, Shen M, Han X, Chen Q, Li L, Chen S, Zhang J, Gao F, Wang W, Wang Y, Li T, Li S, Huang J, Wang J, Zhu J, Chen D, Wu Q, Tao K, Pang D, Jin A (2022) Identification of cross-reactive CD8(+) T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variants. Genes Dis 9:216\u2013229","journal-title":"Genes Dis"},{"key":"3729_CR25","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.bbrc.2016.05.015","volume":"474","author":"H Hamana","year":"2016","unstructured":"Hamana H, Shitaoka K, Kishi H, Ozawa T, Muraguchi A (2016) A novel, rapid and efficient method of cloning functional antigen-specific T-cell receptors from single human and mouse T-cells. Biochem Biophys Res Commun 474:709\u2013714","journal-title":"Biochem Biophys Res Commun"},{"key":"3729_CR26","doi-asserted-by":"publisher","first-page":"W569","DOI":"10.1093\/nar\/gkad356","volume":"51","author":"R Yin","year":"2023","unstructured":"Yin R, Ribeiro-Filho HV, Lin V, Gowthaman R, Cheung M, Pierce BG (2023) TCRmodel2: high-resolution modeling of T cell receptor recognition using deep learning. Nucleic Acids Res 51:W569\u2013W576","journal-title":"Nucleic Acids Res"},{"key":"3729_CR27","doi-asserted-by":"publisher","first-page":"720","DOI":"10.3390\/cells8070720","volume":"8","author":"R Karch","year":"2019","unstructured":"Karch R, Stocsits C, Ilieva N, Schreiner W (2019) Intramolecular domain movements of free and bound pMHC and TCR proteins: a molecular dynamics simulation study. Cells 8:720","journal-title":"Cells"},{"key":"3729_CR28","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMoa1609279","volume":"375","author":"E Tran","year":"2016","unstructured":"Tran E, Robbins PF, Lu YC, Prickett TD, Gartner JJ, Jia L, Pasetto A, Zheng Z, Ray S, Groh EM, Kriley IR, Rosenberg SA (2016) T-cell transfer therapy targeting mutant KRAS in cancer. N Engl J Med 375:2255\u20132262","journal-title":"N Engl J Med"},{"key":"3729_CR29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41586-022-05531-1","volume":"615","author":"SP Foy","year":"2023","unstructured":"Foy SP, Jacoby K, Bota DA, Hunter T, Pan Z, Stawiski E, Ma Y, Lu W, Peng S, Wang CL, Yuen B, Dalmas O, Heeringa K, Sennino B, Conroy A, Bethune MT, Mende I, White W, Kukreja M, Gunturu S, Humphrey E, Hussaini A, An D, Litterman AJ, Quach BB, Ng AHC, Lu Y, Smith C, Campbell KM, Anaya D, Skrdlant L, Huang EY, Mendoza V, Mathur J, Dengler L, Purandare B, Moot R, Yi MC, Funke R, Sibley A, Stallings-Schmitt T, Oh DY, Chmielowski B, Abedi M, Yuan Y, Sosman JA, Lee SM, Schoenfeld AJ, Baltimore D, Heath JR, Franzusoff A, Ribas A, Rao AV, Mandl SJ (2023) Non-viral precision T cell receptor replacement for personalized cell therapy. Nature 615:687\u2013696","journal-title":"Nature"},{"key":"3729_CR30","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1200\/JCO.23.00759","volume":"41","author":"EB Jackson","year":"2023","unstructured":"Jackson EB, Chia SKL (2023) Sequencing of endocrine and targeted therapies in hormone-sensitive, human epidermal growth factor receptor 2-negative advanced breast cancer. J Clin Oncol 41:3976\u20133983","journal-title":"J Clin Oncol"},{"key":"3729_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01945-y","author":"HR Gurung","year":"2023","unstructured":"Gurung HR, Heidersbach AJ, Darwish M, Chan PPF, Li J, Beresini M, Zill OA, Wallace A, Tong AJ, Hascall D, Torres E, Chang A, Lou K, Abdolazimi Y, Hammer C, Xavier-Magalhaes A, Marcu A, Vaidya S, Le DD, Akhmetzyanova I, Oh SA, Moore AJ, Uche UN, Laur MB, Notturno RJ, Ebert PJR, Blanchette C, Haley B, Rose CM (2023) Systematic discovery of neoepitope-HLA pairs for neoantigens shared among patients and tumor types. Nat Biotechnol. https:\/\/doi.org\/10.1038\/s41587-023-01945-y","journal-title":"Nat Biotechnol"},{"key":"3729_CR32","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41591-022-01786-3","volume":"28","author":"SS Chandran","year":"2022","unstructured":"Chandran SS, Ma J, Klatt MG, Dundar F, Bandlamudi C, Razavi P, Wen HY, Weigelt B, Zumbo P, Fu SN, Banks LB, Yi F, Vercher E, Etxeberria I, Bestman WD, Da Cruz Paula A, Aricescu IS, Drilon A, Betel D, Scheinberg DA, Baker BM, Klebanoff CA (2022) Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA. Nat Med 28:946\u2013957","journal-title":"Nat Med"},{"key":"3729_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/565296","volume":"2014","author":"Y Shen","year":"2014","unstructured":"Shen Y, Cao D, Li Y, Kulski JK, Shi L, Jiang H, Ma Q, Yu J, Zhou J, Yao Y, Shi L (2014) Distribution of HLA-A, -B, and -C alleles and HLA\/KIR combinations in Han population in China. J Immunol Res 2014:565296","journal-title":"J Immunol Res"},{"key":"3729_CR34","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1042\/BST20210410","volume":"49","author":"AT Nguyen","year":"2021","unstructured":"Nguyen AT, Szeto C, Gras S (2021) The pockets guide to HLA class I molecules. Biochem Soc Trans 49:2319\u20132331","journal-title":"Biochem Soc Trans"},{"key":"3729_CR35","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1016\/j.vaccine.2007.01.020","volume":"25","author":"IG Ovsyannikova","year":"2007","unstructured":"Ovsyannikova IG, Jacobson RM, Vierkant RA, Pankratz VS, Poland GA (2007) HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design. Vaccine 25:3090\u20133100","journal-title":"Vaccine"},{"key":"3729_CR36","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/intimm\/dxl052","volume":"18","author":"M Lichterfeld","year":"2006","unstructured":"Lichterfeld M, Williams KL, Mui SK, Shah SS, Mothe BR, Sette A, Kim A, Johnston MN, Burgett N, Frahm N, Cohen D, Brander C, Rosenberg ES, Walker BD, Altfeld M, Yu XG (2006) T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily. Int Immunol 18:1179\u20131188","journal-title":"Int Immunol"},{"key":"3729_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.molimm.2011.08.015","volume":"49","author":"S Zhang","year":"2011","unstructured":"Zhang S, Liu J, Cheng H, Tan S, Qi J, Yan J, Gao GF (2011) Structural basis of cross-allele presentation by HLA-A*0301 and HLA-A*1101 revealed by two HIV-derived peptide complexes. Mol Immunol 49:395\u2013401","journal-title":"Mol Immunol"},{"key":"3729_CR38","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1182\/blood-2013-03-490565","volume":"122","author":"GP Linette","year":"2013","unstructured":"Linette GP, Stadtmauer EA, Maus MV, Rapoport AP, Levine BL, Emery L, Litzky L, Bagg A, Carreno BM, Cimino PJ, Binder-Scholl GK, Smethurst DP, Gerry AB, Pumphrey NJ, Bennett AD, Brewer JE, Dukes J, Harper J, Tayton-Martin HK, Jakobsen BK, Hassan NJ, Kalos M, June CH (2013) Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma. Blood 122:863\u2013871","journal-title":"Blood"},{"key":"3729_CR39","doi-asserted-by":"publisher","first-page":"eabl5282","DOI":"10.1126\/science.abl5282","volume":"376","author":"X Zhao","year":"2022","unstructured":"Zhao X, Kolawole EM, Chan W, Feng Y, Yang X, Gee MH, Jude KM, Sibener LV, Fordyce PM, Germain RN, Evavold BD, Garcia KC (2022) Tuning T cell receptor sensitivity through catch bond engineering. Science 376:eabl5282","journal-title":"Science"},{"issue":"3201\u20133213","key":"3729_CR40","volume":"185","author":"L Susac","year":"2022","unstructured":"Susac L, Vuong MT, Thomas C, von Bulow S, O\u2019Brien-Ball C, Santos AM, Fernandes RA, Hummer G, Tampe R, Davis SJ (2022) Structure of a fully assembled tumor-specific T cell receptor ligated by pMHC. Cell 185(3201\u20133213):e3219","journal-title":"Cell"},{"key":"3729_CR41","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/s41587-020-0505-4","volume":"38","author":"H Huang","year":"2020","unstructured":"Huang H, Wang C, Rubelt F, Scriba TJ, Davis MM (2020) Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening. Nat Biotechnol 38:1194\u20131202","journal-title":"Nat Biotechnol"},{"key":"3729_CR42","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41591-019-0472-9","volume":"25","author":"AG Chapuis","year":"2019","unstructured":"Chapuis AG, Egan DN, Bar M, Schmitt TM, McAfee MS, Paulson KG, Voillet V, Gottardo R, Ragnarsson GB, Bleakley M, Yeung CC, Muhlhauser P, Nguyen HN, Kropp LA, Castelli L, Wagener F, Hunter D, Lindberg M, Cohen K, Seese A, McElrath MJ, Duerkopp N, Gooley TA, Greenberg PD (2019) T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant. Nat Med 25:1064\u20131072","journal-title":"Nat Med"},{"key":"3729_CR43","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1182\/blood-2017-05-787598","volume":"131","author":"M Legut","year":"2018","unstructured":"Legut M, Dolton G, Mian AA, Ottmann OG, Sewell AK (2018) CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells. Blood 131:311\u2013322","journal-title":"Blood"},{"key":"3729_CR44","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ymthe.2019.10.001","volume":"28","author":"LT Morton","year":"2020","unstructured":"Morton LT, Reijmers RM, Wouters AK, Kweekel C, Remst DFG, Pothast CR, Falkenburg JHF, Heemskerk MHM (2020) Simultaneous deletion of endogenous TCRalphabeta for TCR gene therapy creates an improved and safe cellular therapeutic. Mol Ther 28:64\u201374","journal-title":"Mol Ther"},{"key":"3729_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100374","volume":"2","author":"TR Muller","year":"2021","unstructured":"Muller TR, Jarosch S, Hammel M, Leube J, Grassmann S, Bernard B, Effenberger M, Andra I, Chaudhry MZ, Kauferle T, Malo A, Cicin-Sain L, Steinberger P, Feuchtinger T, Protzer U, Schumann K, Neuenhahn M, Schober K, Busch DH (2021) Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapy. Cell Rep Med 2:100374","journal-title":"Cell Rep Med"},{"key":"3729_CR46","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1056\/NEJMoa2103485","volume":"385","author":"P Nathan","year":"2021","unstructured":"Nathan P, Hassel JC, Rutkowski P, Baurain JF, Butler MO, Schlaak M, Sullivan RJ, Ochsenreither S, Dummer R, Kirkwood JM, Joshua AM, Sacco JJ, Shoushtari AN, Orloff M, Piulats JM, Milhem M, Salama AKS, Curti B, Demidov L, Gastaud L, Mauch C, Yushak M, Carvajal RD, Hamid O, Abdullah SE, Holland C, Goodall H, Piperno-Neumann S (2021) Overall survival benefit with tebentafusp in metastatic uveal melanoma. N Engl J Med 385:1196\u20131206","journal-title":"N Engl J Med"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-024-03729-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-024-03729-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-024-03729-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T15:12:26Z","timestamp":1721747546000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-024-03729-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["3729"],"URL":"https:\/\/doi.org\/10.1007\/s00262-024-03729-y","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,4]]},"assertion":[{"value":"10 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of The First Affiliated Hospital of Chongqing Medical University. All individuals signed an informed consent form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"150"}}